Design Once, Adapt Smartly: Aligning NICE and JCA evidence strategy early

Event Host

Event Description

As NICE and JCA requirements increasingly need to be considered in parallel, pharmaceutical companies face a growing challenge: how to plan evidence generation efficiently without duplication, delays, or access risks.

Led by our in-house experts, including former NICE team members, this webinar will explore how companies can align NICE and JCA strategies early to improve evidence readiness and support more efficient launch planning.

We’ll compare where NICE and JCA processes, timelines, and evidence expectations intersect, where they differ, and how evidence packages can be designed to support both assessments where possible. The session will also consider where tailored approaches may still be needed, and what this means for organisational readiness, evidence planning, and launch sequencing

Presenters: 

• Charlie Hewitt – Senior Director
• Tomas Keating – Associate Director
• Abigayle Robson – Consultant